World's Best Scientists 2026 revealed!
Amelia Licari

Amelia Licari

D-Index & Metrics

Immunology

D-Index
43
Citations
10849
World Ranking
4818
National Ranking
211

Amelia Licari publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Amelia Licari sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 314 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Amelia Licari D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Amelia Licari sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 43 D-Index — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Best Publications

  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

    Paul Bastard;Paul Bastard;Paul Bastard;Lindsey B. Rosen;Qian Zhang;Eleftherios Michailidis

  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review.

    Riccardo Castagnoli;Martina Votto;Amelia Licari;Ilaria Brambilla

  • Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19

    Unknown

  • An immune-based biomarker signature is associated with mortality in COVID-19 patients.

    Michael S. Abers;Ottavia M. Delmonte;Emily E. Ricotta;Jonathan Fintzi

  • Asthma Endotyping and Biomarkers in Childhood Asthma.

    Amelia Licari;Riccardo Castagnoli;Ilaria Brambilla;Alessia Marseglia

  • The Nose and the Lung: United Airway Disease?

    Amelia Licari;Riccardo Castagnoli;Chiara Francesca Denicolò;Linda Rossini

  • Role of forced expiratory flow at 25-75% as an early marker of small airways impairment in subjects with allergic rhinitis.

    Gian Luigi Marseglia;Ignazio Cirillo;Andrea Vizzaccaro;Catherine Klersy

  • Probiotics and food allergy

    Unknown

  • Omalizumab in Children

    Amelia Licari;Alessia Marseglia;Silvia Caimmi;Riccardo Castagnoli

  • Epidemiology of Allergic Rhinitis in Children: A Systematic Review and Meta-Analysis

    Unknown

  • EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count.

    Stefania Paolucci;Irene Cassaniti;Federica Novazzi;Loretta Fiorina

  • Adenoids during childhood: the facts.

    Unknown

  • Adenoids in children: Advances in immunology, diagnosis, and surgery.

    Unknown

  • Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic.

    Fabio Cardinale;Giorgio Ciprandi;Salvatore Barberi;Roberto Bernardini

  • Impact that the COVID-19 pandemic on routine childhood vaccinations and challenges ahead: a narrative review.

    Elena Chiappini;Sara Parigi;Luisa Galli;Amelia Licari

  • From IgE to clinical trials of allergic rhinitis

    Giorgio Ciprandi;Gian Luigi Marseglia;Riccardo Castagnoli;Chiara Valsecchi

  • Efficacy of Bacillus clausii spores in the prevention of recurrent respiratory infections in children: a pilot study

    Gian Luigi Marseglia;Mariangela Tosca;Ignazio Cirillo;Amelia Licari

  • The discovery and development of omalizumab for the treatment of asthma

    Amelia Licari;GianLuigi Marseglia;Riccardo Castagnoli;Alessia Marseglia

  • Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents.

    Amelia Licari;Riccardo Castagnoli;Alessia Marseglia;Francesca Olivero

  • Difficult vs. Severe Asthma: Definition and Limits of Asthma Control in the Pediatric Population.

    Unknown

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Recently Published Articles